Summary
South Korea’s Ministry of Health and Welfare announced a five-year roadmap through 2028 to expand AI R&D in essential healthcare, serious diseases, emergency care, cancer and new drug development, while strengthening medical data platforms and ethical guidelines for AI in medicine.
Healthcare Implications
The roadmap aims to double commercialisation of medical AI technologies, improve access to pseudonymised health data for research and embed AI in clinical trials and hospital workflows, positioning Korea’s health system as an early adopter of AI-enabled care and drug development.